Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU approval for clothianidin biocide

Formal EU approval has been issued for non-crop use of the neonicotinoid insecticide, clothianidin. It is for use against house flies in animal housing and domestic premises. The authorisation commences on October 1st 2016 to allow time for authorities and applicants to adapt to the approval conditions. The active ingredient is classified as a candidate for substitution and member states must consider whether safer alternatives are available when approving products. Authorisations are not permitted for: animal housings other than for beef cattle; and housings where emissions to water or sewage treatment plants cannot be prevented. Member states must also ensure safe-use practices for industrial or professional users, and review maximum residue limits if use may lead to residues in food or feed. Clothianidin was assessed under the EU review of existing biocides, and was cleared by EU member states earlier this year. It already holds biocide approval as a wood preservative.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022688

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel